West Pharmaceutical Services Return on Investment 2010-2022 | WST

Current and historical return on investment (ROI) values for West Pharmaceutical Services (WST) over the last 10 years.
West Pharmaceutical Services ROI - Return on Investment Historical Data
Date TTM Net Income LT Investments & Debt Return on Investment
2022-06-30 $0.78B $2.63B 30.94%
2022-03-31 $0.77B $2.54B 31.35%
2021-12-31 $0.75B $2.54B 32.27%
2021-09-30 $0.68B $2.41B 30.80%
2021-06-30 $0.60B $2.28B 28.52%
2021-03-31 $0.50B $2.08B 24.69%
2020-12-31 $0.41B $2.11B 21.19%
2020-09-30 $0.37B $1.97B 19.93%
2020-06-30 $0.34B $1.86B 18.94%
2020-03-31 $0.31B $1.75B 18.21%
2019-12-31 $0.30B $1.83B 17.69%
2019-09-30 $0.29B $1.68B 17.59%
2019-06-30 $0.28B $1.64B 17.59%
2019-03-31 $0.26B $1.57B 16.69%
2018-12-31 $0.24B $1.59B 15.68%
2018-09-30 $0.23B $1.55B 15.58%
2018-06-30 $0.24B $1.48B 15.81%
2018-03-31 $0.22B $1.50B 14.70%
2017-12-31 $0.23B $1.48B 15.61%
2017-09-30 $0.22B $1.51B 15.48%
2017-06-30 $0.21B $1.44B 15.01%
2017-03-31 $0.23B $1.36B 16.69%
2016-12-31 $0.20B $1.34B 14.56%
2016-09-30 $0.19B $1.37B 14.20%
2016-06-30 $0.13B $1.34B 10.31%
2016-03-31 $0.11B $1.30B 8.79%
2015-12-31 $0.13B $1.25B 10.50%
2015-09-30 $0.13B $1.23B 10.48%
2015-06-30 $0.18B $1.22B 14.24%
2015-03-31 $0.19B $1.17B 15.11%
2014-12-31 $0.18B $1.27B 13.98%
2014-09-30 $0.17B $1.29B 13.33%
2014-06-30 $0.17B $1.33B 13.20%
2014-03-31 $0.16B $1.33B 12.72%
2013-12-31 $0.16B $1.28B 13.45%
2013-09-30 $0.16B $1.22B 13.51%
2013-06-30 $0.14B $1.18B 12.69%
2013-03-31 $0.14B $1.17B 12.64%
2012-12-31 $0.14B $1.11B 13.10%
2012-09-30 $0.13B $1.08B 13.10%
2012-06-30 $0.13B $0.98B 13.32%
2012-03-31 $0.12B $0.99B 12.23%
2011-12-31 $0.11B $0.95B 10.84%
2011-09-30 $0.09B $1.02B 8.70%
2011-06-30 $0.09B $1.06B 8.64%
2011-03-31 $0.09B $1.03B 9.24%
2010-12-31 $0.09B $0.98B 9.48%
2010-09-30 $0.11B $1.00B 11.22%
2010-06-30 $0.11B $0.93B 11.45%
2010-03-31 $0.11B $0.93B 11.26%
2009-12-31 $0.10B $0.96B 10.57%
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $18.245B $2.832B
West Pharmaceutical Services Inc. is a leading global manufacturer with respect to design and production of technologically advanced, high-quality, integrated containment and delivery systems for injectable drugs and healthcare products. The Exton, PA-based company designs and produces these medical products in the Americas, Europe, the Middle East, Africa and the Asia Pacific. Its primary objective is to deliver quality products that cater to the exact product specifications and quality standards that customers expect and need. West Pharmaceutical operates through two segments: Proprietary Products and Contract-Manufactured Products.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $65.121B 18.92
McKesson (MCK) United States $49.080B 14.25
AmerisourceBergen (ABC) United States $28.071B 12.53
Laboratory Of America Holdings (LH) United States $19.156B 8.38
Cardinal Health (CAH) United States $18.043B 13.09
Cooper (COO) United States $13.018B 20.37
CONMED (CNMD) United States $2.370B 23.36
Invacare (IVC) United States $0.030B 0.00